Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Mar 17, 2025
Date Accepted: Jul 18, 2025

The final, peer-reviewed published version of this preprint can be found here:

Small-Area Lung Cancer Incidence and Mortality: Cross-Sectional Population-Based Study Using Hospital Discharge and Death Registration Data

He Y, Xia X, Wang Q, Zhang Y, Meng Y, Ji X, Zhao Q, Wang Y, Zhao Y, Xue F, Xu J

Small-Area Lung Cancer Incidence and Mortality: Cross-Sectional Population-Based Study Using Hospital Discharge and Death Registration Data

JMIR Public Health Surveill 2025;11:e74062

DOI: 10.2196/74062

PMID: 41021842

PMCID: 12478967

Small-area Lung Cancer Incidence and Mortality: Cross-sectional Population-based Study using Hospital Discharge and Death Registration Data

  • Yu He; 
  • Xinxin Xia; 
  • Qing Wang; 
  • Yaoyun Zhang; 
  • Ying Meng; 
  • Xiaokang Ji; 
  • Qingbo Zhao; 
  • Yongchao Wang; 
  • Yifu Zhao; 
  • Fuzhong Xue; 
  • Jin Xu

ABSTRACT

Background:

Despite rapid development of cancer registries in low- and middle-income countries like China, it has the persistent problems with delayed reports and lack of details about small-size areas.

Objective:

This study aimed to develop a new approach for cancer surveillance based on linked administrative data about hospital discharges and death registration.

Methods:

This population-based cohort study was based on the hospitalization record front pages (HRFPs) between 2013 and 2022 from all the secondary and tertiary hospitals and death registration in Shandong Province, China. Incident cases of and deaths from lung cancer were ascertained for 2022. We estimated age-standardized incidence and mortality rates (ASIR and ASMR) of lung cancer in 2022 using Segi’s World Standard Population, age-specific incidence and mortality rates by sex, and the ASIR and ASMR stratified by county to illustrate regional disparity.

Results:

Taking 2013-2021 as the washout period, the HRFP captured 79,672 incident cases of lung cancer in Shandong in 2022 (45,527 males, 34,145 females). The ASIR of lung cancer in Shandong was 42.46 per 100,000 in both sexes (49.19/100,000 in male vs. 36.67/100,000 in female). A total of 40,626 lung cancer-specific deaths were ascertained (28,185 men and 12,441 women). The ASMR was 19.76 per 100,000 in both sexes, 26.29/100,000 and 11.38/100,000 in males and females, respectively. The interquartile range of county-level ASIR and ASMR were 17.13/100,000 and 10.41/100,000, respectively.

Conclusions:

The cancer surveillance approach based on linked administrative data could provide up-to-date small-area estimates of cancer burden when cancer registry data are not yet reported and for areas not covered by cancer registries. It could further reveal disparity of cancer epidemiology, the reasons behind which is worth further investigation.


 Citation

Please cite as:

He Y, Xia X, Wang Q, Zhang Y, Meng Y, Ji X, Zhao Q, Wang Y, Zhao Y, Xue F, Xu J

Small-Area Lung Cancer Incidence and Mortality: Cross-Sectional Population-Based Study Using Hospital Discharge and Death Registration Data

JMIR Public Health Surveill 2025;11:e74062

DOI: 10.2196/74062

PMID: 41021842

PMCID: 12478967

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.